Bollschweiler E - Search Results

1

Novel diagnostic and prognostic biomarkers in esophageal cancer.

Plum PS, Bollschweiler E, Hölscher AH, Warnecke-Eberz U. Plum PS, et al. Among authors: bollschweiler e. Expert Opin Med Diagn. 2013 Nov;7(6):557-71. doi: 10.1517/17530059.2013.843526. Epub 2013 Oct 4. Expert Opin Med Diagn. 2013. PMID: 24093836 Review.

2

Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?

Bollschweiler E, Baldus SE, Schröder W, Schneider PM, Hölscher AH. Bollschweiler E, et al. J Surg Oncol. 2006 Oct 1;94(5):355-63. doi: 10.1002/jso.20569. J Surg Oncol. 2006. PMID: 16967455

3

Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer.

Bollschweiler E, Hölscher AH, Metzger R. Bollschweiler E, et al. Future Oncol. 2010 Jan;6(1):25-35. doi: 10.2217/fon.09.133. Future Oncol. 2010. PMID: 20021207 Review.

4

Prognostic relevance of skip metastases in esophageal cancer.

Prenzel KL, Bollschweiler E, Schröder W, Mönig SP, Drebber U, Vallboehmer D, Hölscher AH. Prenzel KL, et al. Among authors: bollschweiler e. Ann Thorac Surg. 2010 Nov;90(5):1662-7. doi: 10.1016/j.athoracsur.2010.07.008. Ann Thorac Surg. 2010. PMID: 20971285

5

ERCC1: impact in multimodality treatment of upper gastrointestinal cancer.

Metzger R, Bollschweiler E, Hölscher AH, Warnecke-Eberz U. Metzger R, et al. Among authors: bollschweiler e. Future Oncol. 2010 Nov;6(11):1735-49. doi: 10.2217/fon.10.140. Future Oncol. 2010. PMID: 21142660 Review.

6

Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer.

Narumiya K, Metzger R, Bollschweiler E, Alakus H, Brabender J, Drebber U, Hölscher AH, Warnecke-Eberz U. Narumiya K, et al. Among authors: bollschweiler e. Pharmacogenomics. 2011 Feb;12(2):205-14. doi: 10.2217/pgs.10.174. Pharmacogenomics. 2011. PMID: 21332314

7

Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer.

Hölscher AH, Bollschweiler E, Schröder W, Metzger R, Gutschow C, Drebber U. Hölscher AH, et al. Among authors: bollschweiler e. Ann Surg. 2011 Nov;254(5):802-7; discussion 807-8. doi: 10.1097/SLA.0b013e3182369128. Ann Surg. 2011. PMID: 22042472

8

Prognostic relevance of nutritional status in patients with advanced esophageal cancer.

Bollschweiler E, Herbold T, Plum P, Hölscher AH. Bollschweiler E, et al. Expert Rev Anticancer Ther. 2013 Mar;13(3):275-8. doi: 10.1586/era.12.176. Expert Rev Anticancer Ther. 2013. PMID: 23477514

9

Frequency of lymph node metastasis in submucosal esophageal cancer.

Hölscher AH, Bollschweiler E. Hölscher AH, et al. Among authors: bollschweiler e. Ann Surg. 2014 Jun;259(6):e84. doi: 10.1097/SLA.0000000000000298. Ann Surg. 2014. PMID: 24169170 No abstract available.

10

Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy.

Alakus H, Bollschweiler E, Hölscher AH, Warnecke-Eberz U, Frazer KA, Harismendy O, Lowy AM, Mönig SP, Eberz PM, Maus M, Drebber U, Siffert W, Metzger R. Alakus H, et al. Among authors: bollschweiler e. Ann Surg Oncol. 2014 Dec;21(13):4375-82. doi: 10.1245/s10434-014-3843-y. Epub 2014 Jul 2. Ann Surg Oncol. 2014. PMID: 24986238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page